KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Short-Term Debt issuances (2016 - 2025)

National Health Investors (NHI) has disclosed Short-Term Debt issuances for 16 consecutive years, with $189.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-Term Debt issuances fell 8.12% year-over-year to $189.0 million, compared with a TTM value of $694.0 million through Dec 2025, up 54.33%, and an annual FY2025 reading of $694.0 million, up 54.33% over the prior year.
  • Short-Term Debt issuances was $189.0 million for Q4 2025 at National Health Investors, up from $176.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $261.0 million in Q1 2025 and bottomed at $10.0 million in Q2 2022.
  • Average Short-Term Debt issuances over 5 years is $96.2 million, with a median of $68.0 million recorded in 2025.
  • The sharpest move saw Short-Term Debt issuances plummeted 76.0% in 2021, then skyrocketed 342.37% in 2025.
  • Year by year, Short-Term Debt issuances stood at $35.0 million in 2021, then surged by 71.43% to $60.0 million in 2022, then soared by 35.0% to $81.0 million in 2023, then surged by 153.95% to $205.7 million in 2024, then decreased by 8.12% to $189.0 million in 2025.
  • Business Quant data shows Short-Term Debt issuances for NHI at $189.0 million in Q4 2025, $176.0 million in Q3 2025, and $68.0 million in Q2 2025.